RNA based therapeutics have the potential to treat diseases such as cancer and rare genetic disorders by turning on and off the production of dysfunctional proteins in affected cells. However, RNA is inherently unstable, potentially immunogenic, and typically requires a delivery vehicle for efficient transport to the targeted cells. Historically, these issues have hindered the clinical progress of RNA-based drugs. However, recent advances (and significant investment) in the field has resulted in several promising candidates enter late stage clinical testing.
This event will provide a general overview of the progress RNA therapeutics are making towards becoming viable therapeutic options in the clinic, the approach to drug discovery within the RNA therapeutics field, the different types of RNA therapeutics in development and the potential for medical devices to reduce the challenges associated with RNA therapeutic delivery.
3.00 Welcome and Introduction
Mads Aaboe Jensen Principal Scientist, Drug Discovery & Alliance RNA Therapeutics Research, Roche Innovation Center Copenhagen RNA Therapeutics – A Large Pharma perspective
Prof. David Henshall & Prof. Fergal O’Brien Royal College of Surgeon in Ireland RNA Therapeutics - A translational research perspective
Aiden Flanagan Principal Development Engineer, Boston Scientific RNA Therapeutics – A Medical Device Industry perspective 4.30 Open Mike Session (3-minute presentations)
4.30 Open Mike Session (3-minute presentations)
5.00 Network Reception